Zeb1 potentiates genome-wide gene transcription with Lef1 to promote glioblastoma cell invasion.

Pedro Rosmaninho, Susanne Mükusch, Valerio Piscopo, Vera Teixeira, Alexandre Asf Raposo, Rolf Warta, Romina Bennewitz, Yeman Tang, Christel Herold-Mende, Stefano Stifani, Stefan Momma, Diogo S Castro

Journal: The EMBO journal 2019;37(15):e97115

PMID: 29903919

Abstract

Glioblastoma is the most common and aggressive brain tumor, with a subpopulation of stem-like cells thought to mediate its recurring behavior and therapeutic resistance. The epithelial-mesenchymal transition (EMT) inducing factor Zeb1 was linked to tumor initiation, invasion, and resistance to therapy in glioblastoma, but how Zeb1 functions at molecular level and what genes it regulates remain poorly understood. Contrary to the common view that EMT factors act as transcriptional repressors, here we show that genome-wide binding of Zeb1 associates with both activation and repression of gene expression in glioblastoma stem-like cells. Transcriptional repression requires direct DNA binding of Zeb1, while indirect recruitment to regulatory regions by the Wnt pathway effector Lef1 results in gene activation, independently of Wnt signaling. Amongst glioblastoma genes activated by Zeb1 are predicted mediators of tumor cell migration and invasion, including the guanine nucleotide exchange factor Prex1, whose elevated expression is predictive of shorter glioblastoma patient survival. Prex1 promotes invasiveness of glioblastoma cells highlighting the importance of Zeb1/Lef1 gene regulatory mechanisms in gliomagenesis.

© 2018 The Authors.

Address: Molecular Neurobiology Laboratory, Instituto Gulbenkian de Ciência, Oeiras, Portugal.; Institute of Neurology (Edinger Institute), Frankfurt University Medical School, Frankfurt, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.; Division of Experimental Neurosurgery, Department of Neurosurgery, University Hospital of Heidelberg, Heidelberg, Germany.; Institute of Neurology (Edinger Institute), Frankfurt University Medical School, Frankfurt, Germany [email protected] [email protected].; Molecular Neurobiology Laboratory, Instituto Gulbenkian de Ciência, Oeiras, Portugal [email protected] [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.